What causes the tissue-specific pathology of diseases resulting from mutations in housekeeping genes? Specifically, in spinocerebellar ataxia type 7 (SCA7), a neurodegenerative disorder caused by a CAG-repeat expansion in ATXN7 (which encodes an essential component of the mammalian transcription coactivation complex, STAGA), the factors underlying the characteristic progressive cerebellar and retinal degeneration in patients were unknown. We found that STAGA is required for the transcription initiation of miR-124, which in turn mediates the post-transcriptional cross-talk between lnc-SCA7, a conserved long noncoding RNA, and ATXN7 mRNA. In SCA7, mutations in ATXN7 disrupt these regulatory interactions and result in a neuron-specific increase in ATXN7 expression. Strikingly, in mice this increase is most prominent in the SCA7 disease-relevant tissues, namely the retina and cerebellum. Our results illustrate how noncoding RNA-mediated feedback regulation of a ubiquitously expressed housekeeping gene may contribute to specific neurodegeneration.
SCA7 is a rare inherited neurodegenerative disease that affects approximately 1 in 100,000 people 1 . Like other spinocerebellar ataxias, SCA7 is characterized by uncoordinated movement, abnormal gait, dysarthria and dysphagia, all due to selective neuronal death of Purkinje cells in the cerebellum 2 . Unique to SCA7 is the degeneration of the retinal macula, leading to gradual loss of sight and eventually to blindness 3 . SCA7 is caused by an in-frame CAG trinucleotide-repeat expansion in the first coding exon of the ataxin type 7 gene, ATXN7 (ref. 2) . Translation of the mutated ATXN7 allele results in polyglutamine (polyQ)-tract expansion, formation of protein aggregates and decreased protein activity 4 .
ATXN7 is an essential component of the mammalian STAGA multiprotein complex 5 , whose chromatin-remodeling activity facilitates transcriptional activation of multiple loci. ATXN7 expression is not specific to the brain but instead is found at similarly high levels in many non-neuronal tissues, such as the kidney, liver and lung 2, 6 . Why mutations in this ubiquitously expressed housekeeping gene lead to the degeneration of only retinal and cerebellar neurons has remained unresolved.
We hypothesized that regulation by noncoding RNAs, whose expression pattern is often spatially and developmentally restricted 7 , might contribute to SCA7's tissue-specific pathology. For instance, aberrant expression of microRNAs (miRNAs) has previously been associated with disease (reviewed in ref. 8) : decreased expression of both miR-9 and miR-9 passenger (star) strands has been found in the cortices of patients with Huntington's disease 9, 10 , whereas inhibition of miR-19, miR-101 and miR-130 increased the cytotoxicity of polyQ-expanded ATXN1 in spinocerebellar ataxia type 1 (ref. 11) . The importance of miRNAs for the survival of neuronal subtypes is clear from the observation that global loss of miRNAs in mice, achieved by conditional knockout of Dicer1 (a gene required for miRNA biogenesis, here denoted Dcr), led to the progressive degeneration of specific types of neurons in the CNS, including retinal and cerebellar cells 12, 13 . These particular phenotypes are driven, at least in part, by the loss of miR-124, the most abundantly expressed miRNA in the CNS 14 , because targeted deletion of this miRNA in mice partially mimicked Dcr knockout and resulted in increased degeneration of retinal and neuronal cells 15 , the two cell types with the highest miR-124 expression.
Similarly to miRNAs, long (>200-nucleotide) noncoding RNAs (lncRNAs), whose expression is often spatially and temporally restricted 16, 17 , have also been previously associated with neurodegeneration 18 . Spinocerebellar ataxia type 8 (SCA8) 19 , for instance, is caused by the toxicity of a CUG trinucleotide-repeat expansion in the lncRNA antisense to ATXN8 as well as by the loss of function A r t i c l e s of the polyQ-expanded mutant ATXN8 protein 20 . As in SCA8, ribonuclear inclusions have been found in other polyQ disorders, such as myotonic dystrophy and Huntington's disease-like type 2 (ref. 21) , thus suggesting that repeat-expanded RNA may be pathogenic. lncRNAs can also contribute to disease by regulating transcript abundance of their overlapping disease-causing genes, as found for BACE1-AS, in Alzheimer's disease 22 , and for SCAANT1, a noncoding transcript overlapping ATXN7 (ref. 23) . Several intergenic lncRNAs have been found to be dysregulated in patients with Huntington's 24 or Alzheimer's 25 diseases, and an intergenic lncRNA was recently found to be correlated in expression with a strong intergenic risk allele for Parkinson's disease 26 . However, whether such associations reflect causal contributions by intergenic lncRNAs or are consequences of the disease pathology remains unknown.
We sought to establish the origin of the tissue-specific pathology of SCA7 by investigating the regulation of ATXN7, a ubiquitously expressed gene, by tissue-specifically expressed noncoding RNAs. Our results demonstrate that the regulation of the abundance of mutant ATXN7 through cross-talking noncoding RNAs that are highly specific to the retina and the cerebellum contributes to the selective neurodegeneration observed in SCA7.
RESULTS

lnc-SCA7 is a post-transcriptional regulator of Atxn7
We identified a retropseudogene, lnc-SCA7 (official symbol ATXN7L3B) that is unusually conserved across placental mammals and whose expression is significantly correlated with that of ATXN7 across human and mouse adult tissues and postnatal central nervous system (CNS) regions ( Fig. 1a and Supplementary Fig. 1 ). In mice, this correlation is stronger in CNS regions (Pearson's R 2 = 0.94, P < 0.001, two-tailed correlation test; n = 10 CNS regions and 10 non-CNS regions) than elsewhere (Pearson's R 2 = 0.69, P < 0.05; Supplementary  Fig. 1b) , thus suggesting that an additional layer of regulation could control the relative abundance of both transcripts in these regions.
lnc-SCA7 arose from retrotransposition of the gene encoding ataxin-7-like protein 3 (Atxn7l3), a distant paralog of Atxn7, in the common ancestor of placental mammals approximately 100 million years ago. We found no homology between the 1-kb genomic regions upstream of Atxn7l3 and of lnc-SCA7, results indicating that they are unlikely to have homologous promoters. lnc-SCA7 inserted downstream of a preexisting CpG island, and its duplication accumulated frameshifting deletions that resulted in premature stop codons and a truncated open reading frame (ORF) (Supplementary Fig. 1c ). The small putative polypeptide (97 amino acids) encoded by lnc-SCA7 lacks the two annotated functional ATXN7L3 protein domains ( Supplementary  Fig. 1d ). Despite both transcripts being expressed at similarly high levels in mouse neuroblastoma cells (N2A; Supplementary Fig. 1e ), a custom antibody raised against the N-terminal protein sequence conserved between Atxn7l3 and the putative lnc-SCA7 protein ( Supplementary  Fig. 1c ) detected translation of ATXN7L3 (predicted size 39 kDa) but not of a polypeptide of the size expected for lnc-SCA7 protein (11 kDa; Supplementary Fig. 1f and Supplementary Data Set 1). The transcript originating from this gene is thus unlikely to be translated into a stable protein product in these cells.
The coordinated expression between lnc-SCA7 and Atxn7 in both mice and humans prompted us to explore whether this long noncoding RNA regulates Atxn7's transcript abundance. In mouse N2A cells, lnc-SCA7 depletion (up to 20% of control) by multiple target-specific short hairpin RNA (shRNA) constructs ( Supplementary Fig. 2a ) significantly reduced Atxn7 transcript levels (up to 60% of control; Fig. 1b and Supplementary Fig. 2b ) and Atxn7 protein levels (by approximately 60% of control; Fig. 1c and Supplementary Data Set 1). Furthermore, in N2A cells, overexpression (6.8-fold) of the region downstream of lnc-SCA7's putative stop codon (nucleotides 599-3607, hereafter termed lnc-SCA7-WT) significantly increased levels of Atxn7 transcript (2.3-fold; Fig. 1d ) and Atxn7 protein ( Fig. 1e and Supplementary Data Set 1). We observed comparable increases in Atxn7 transcript levels upon overexpression of either full-length lnc-SCA7 sequence (lnc-SCA7-full) or a recombinant mutant with a premature stop codon (lnc-SCA7-stop; Fig. 1d and Online Methods).
We conclude that, in mice, lnc-SCA7 modulates the expression of Atxn7 via a transcript-dependent mechanism that does not rely on the translation of its putative ORF. Given its cytoplasmic localization ( Supplementary Fig. 2c ), we hypothesized that, similarly to other lncRNAs 27 , lnc-SCA7 modulates Atxn7 expression posttranscriptionally by competing for the binding of shared miRNAs. A r t i c l e s
miR-124 mediates interaction of lnc-SCA7 and Atxn7 transcripts
To test this hypothesis, we took advantage of a mouse embryonic stem (ES) cell line that is conditionally deficient for Dicer (Dcr ∆/∆ ), an essential component of the miRNA biogenesis pathway in mammals 28 . We found that, as observed in N2A cells, lnc-SCA7 knockdown (76% relative to control) in wild-type ES cells significantly reduced the expression of Atxn7 (82% of control; Fig. 2a ).
In contrast, in Dcr-deficient ES cells a similar level of lnc-SCA7 knockdown had no significant effect on Atxn7 expression ( Fig. 2b) . This is consistent with the regulation of Atxn7 expression by lnc-SCA7 being miRNA-dependent. Of all brain-expressed miRNAs, only two, miR-16 and miR-124, have corresponding predicted miRNA-response elements (MREs) within the 3′ untranslated regions (UTRs) of both Atxn7 and lnc-SCA7 that are conserved (between mice and humans) ( Fig. 2c , Supplementary Fig. 3a,b and Supplementary Table 1 ). In contrast to miR-16, which has no known role in the brain, miR-124 is the most abundantly expressed miRNA in the CNS 14 and has well-established roles in neuronal development 29 .
Transfection of N2A cells with miR-124 mimics reduced lnc-SCA7 and Atxn7 expression levels relative to those after transfection of a nonspecific miRNA negative control (32% and 19% of control, respectively; Fig. 2d ), whereas reduction of endogenous levels of miR-124 (62% of control) led to significant increases in expression of both lnc-SCA7 and Atxn7 (by 1.8-and 2.5-fold, respectively; Fig. 2e ).
In contrast, miR-16 mimics failed to significantly alter the levels of these transcripts ( Supplementary Fig. 3c ). These findings, together with miR-16's considerably lower abundance ( Supplementary Fig. 3d ), indicated that miR-124 but not miR-16 is likely to mediate cross-talk between lnc-SCA7 and Atxn7 transcripts in mouse neurons.
This conclusion was further supported by the dependence of the reduction in reporter activity after cotransfection of miR-124 mimics and recombinant lnc-SCA7 or Atxn7 luciferase-reporter constructs (23% and 42% of control, respectively; Fig. 2f ) on the presence of the predicted miR-124 MREs in these transcripts. More specifically, transfected constructs bearing inverted seed sequences of all miR-124 MREs predicted within lnc-SCA7 (six MREs) and Atxn7 (two MREs) (hereafter referred to as lnc-SCA7-mut and Atxn7-mut, respectively) abolished the effect of miR-124 on reporter activity ( Fig. 2f) . As expected, neither lnc-SCA7-mut nor Atxn7-mut overexpression (7.7-and 9.7-fold, respectively) had a significant impact on transcript levels of Atxn7 (Fig. 2g ) or lnc-SCA7 ( Fig. 2h) , consistently with the ability of lnc-SCA7 and Atxn7 transcripts to modulate each other's abundance in a miR-124-dependent manner.
A feedback loop involving ATXN7 mRNA and miR-124
Reduction in lnc-SCA7 levels surprisingly led to depletion of both mature (23% of control; Fig. 3a ) and precursor-miR-124 levels (47% of control; Supplementary Fig. 4a ). Decreased levels (63% of control) of lnc-SCA7 in human neuroblastoma cells (SH-SY5) were associated A r t i c l e s with decreased expression levels of both ATXN7 (84% of control) and primary (pri)-miR-124a_1 (87% of control), consistently with the conservation of regulatory interactions in humans ( Supplementary  Fig. 4b ). Furthermore, and as seen in mouse neuroblastoma cells, decreased levels of endogenous miR-124 were associated with increased lnc-SCA7 and ATXN7 transcript abundance in these cells ( Supplementary Fig. 4c) , consistently with the evolutionary conservation of cross-talk between these transcripts. Changes in miR-124 levels do not reflect a general effect of lnc-SCA7 on miRNA expression or processing because genome-wide analysis of miRNA abundance revealed no significant differences in N2A miRNA repertoires after either knockdown or overexpression of lnc-SCA7 (Supplementary Table 2 and Online Methods). This suggested that lnc-SCA7 abundance correlates with the rate of transcription of precursor-miR-124 loci and that STAGA might be required for miR-124 transcriptional initiation. To test this hypothesis, we first identified the putative promoters of the three pri-miR-124-encoding genes (Mir124a-1, Mir124a-2 and Mir124a-3) as their nearest upstream DNase I-hypersensitivity region that was marked with acetylated histone H3 K27 (H3K27ac) in mouse cerebellum ( Supplementary Fig. 4d-f) . STAGA is required for the transcriptional activation of miR-124 loci: each of these promoters exhibited reporter activity at least 8.5-fold higher than that for the control antisense sequence (Supplementary Fig. 4g ) and was bound by Gcn5, STAGA's histone acetyltransferase 5 , at 2.0-to 3.5-fold greater levels than for IgG control (Fig. 3b) . Furthermore, although overexpression of lnc-SCA7-WT increased luciferase activity for all three miR-124 promoters (1.5-to 1.8-fold), we detected no significant changes in activity after overexpression of lnc-SCA7-mut (Fig. 3c) . Accordingly, lnc-SCA7 knockdown decreased Gcn5 binding (Supplementary Fig. 4h ) and luciferase activity for each of the three miR-124 promoters (Supplementary Fig. 4i ). Furthermore, overexpression of Atxn7-WT led to a significantly higher increase of miR-124 promoter activity (Supplementary Fig. 4j ) and precursor miR-124 levels ( Supplementary  Fig. 4k ) than did Atxn7-mut.
In summary, Atxn7 transcripts promote miR-124 transcription initiation; in turn, miR-124 is key to the post-transcriptional cross-talk between lnc-SCA7, Atxn7 transcripts and other STAGA mRNAs in the CNS (Supplementary Note), predominantly in the tissues in which miR-124 is more highly expressed, namely the retina and the cerebellum (Supplementary Fig. 5 ).
Noncoding RNAs mediate SCA7's tissue-specific pathology
In SCA7, the polyQ-expanded ATXN7 protein is associated with decreased STAGA chromatin-modification activity 30, 31 and with reduced levels of transcripts from loci relying on STAGA transcriptional initiation 32 . The regulatory feedback loop (Fig. 4a ) revealed by our in vitro analysis predicts that a decrease in STAGA activity in SCA7 would result in: (i) diminished pri-miR-124 transcriptional initiation and, as a consequence, (ii) decreased mature miR-124 and (iii) increased lnc-SCA7 levels (Fig. 4b) .
We first validated these predictions in a human model of SCA7 by comparing the levels of ATXN7, lnc-SCA7 and miR-124 in fibroblasts derived from three patients with SCA7, who carry 42, 49 or 55 polyQ-repeat expansions in ATXN7, against the levels in control fibroblasts (with ten polyQ-repeats). Expression levels of miR-124 A r t i c l e s were reduced by more than two-fold (45% of control), whereas transcript abundance of lnc-SCA7 and ATXN7 increased substantially (by up to 1.8-fold and 5.2-fold, respectively) in these patients' cells ( Fig. 5a) . Furthermore, decreased levels of endogenous miR-124 (62% of control) in human fibroblasts were associated with increased expression of both lnc-SCA7 and ATXN7 (1.22-and 1.27-fold, respectively; Supplementary Fig. 6) ; this supports the direct contribution of this miRNA to the post-transcriptional modulation of these two transcripts' levels in fibroblasts.
Furthermore, we predict that changes in miR-124 abundance would result in the post-transcriptional derepression of mutant ATXN7 mRNA and consequently in increased abundance of its encoded protein, with this effect being more prominent in tissues in which the miRNA has the greatest effect on ATXN7 transcript abundance. The cross-talk between ATXN7 and lnc-SCA7 transcripts in tissues in which miR-124 levels are high is likely to be enhanced, consistently with the observed higher correlation of levels of these transcripts in the CNS ( Supplementary  Fig. 1b) ; this cross-talk might also amplify, post-transcriptionally, the impact of changes in miR-124 levels on ATXN7's abundance (Fig. 4b) .
To test the validity of our predictions and the higher impact of noncoding-RNA deregulation in the tissues primarily affected in disease, we took advantage of two established knock-in (KI) SCA7 mouse models: homozygous SCA7 100Q/100Q (ref. 33 ) and heterozygous SCA7 266Q/5Q (ref. 34 ). The two models express full-length human ATXN7 with 100 or 266 CAG (polyQ) repeats, respectively, inserted into the endogenous mouse Atxn7 locus. Both mouse models exhibit typical ataxic symptoms as well as the unique retinal degeneration specific to SCA7 (refs. 33, 34) . Consistently with observations in human patients 2 , SCA7 mice that carry a higher number of polyQ repeats show earlier disease onset and increased disease severity 34 . We took advantage of the interval separating disease onset for the two SCA7 mouse models and tested our predictions, using both symptomatic (28-week-old SCA7 100Q/100Q ) and presymptomatic (5-week-old SCA7 266Q/5Q ) animals.
First, we investigated whether mutations in ATXN7 decrease the binding of STAGA upstream of the promoter regions of the three pri-miR-124encoding genes. Indeed, in the cerebellums of the SCA7 100Q/100Q mice, relative to wild-type matched-control mice (SCA7 5Q/5Q ), STAGA bound with significantly reduced levels (48-79% reduction) to all three promoters of pri-miR-124-encoding genes (Fig. 5b) , as expected given our finding that miR-124 loci are targets of the STAGA complex. Next we compared, between SCA7 KI mice and wild-type controls, the transcript abundances of ATXN7, lnc-SCA7 and miR-124 in nine tissues: the two CNS regions primarily affected in disease (the retina and cerebellum), four CNS regions largely unaffected by the disease (the striatum, olfactory bulb, cortex and spinal cord) and three non-CNS tissues (muscle, lung and liver). As expected, levels of mature miR-124 were significantly decreased in the CNS tissues in SCA7 mouse models, in which this miRNA is normally more highly expressed (up to 77% of control), to result in elevated abundance of its targets, lnc-SCA7 (up to 3.8-fold) and ATXN7 mRNA (up to 2.6-fold; Fig. 5c and Supplementary Fig. 7a-h) . As predicted, within the CNS the relative change between wild-type and SCA7 KI in miR-124 levels and associated fold increases in the expression of lnc-SCA7 and ATXN7 were highest in the two tissues primarily affected in disease, the retina and the cerebellum ( Fig. 5c and Supplementary Fig. 7a-d) . We tested the impact of these changes on the levels of known miR-124 targets [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] and found that 8 and 12 out of the 13 transcripts tested were significantly upregulated in the cerebellum and retina, respectively ( Supplementary  Fig. 7i,j) . In contrast, in the three non-CNS tissues tested (muscle, lung and liver), we found no significant changes in ATXN7 or lnc-SCA7 transcript levels in both SCA7 KI mouse models ( Supplementary  Fig. 7k-o) . Absolute ATXN7 and lnc-SCA7 transcript abundance, measured with droplet digital PCR in the retina, cerebellum, liver and lung of wild-type and SCA7 KI mice, strongly correlated with the levels estimated by standard quantitative real-time PCR with reverse transcription (qRT-PCR; Supplementary Fig. 8 and Supplementary Table 3 ). Interestingly, we detected increased levels of mutant ATXN7 mRNA and reduced levels of miR-124 in the retina and the cerebellum before SCA7 onset in the heterozygous SCA7 266Q/5Q mice (Fig. 5d,e ).
Our findings are concordant with cross-talking noncoding RNAs contributing to the tissue-specific disease pathology of SCA7: differences in miR-124, ATXN7 and lnc-SCA7 expression levels were more pronounced in the retina and cerebellum, tissues that have been shown to exhibit primary signs of cellular degeneration in SCA7 (ref. 2). A r t i c l e s neurons observed in patients with SCA7 has thus far remained unexplained. Our in vitro and in vivo analyses in mice suggest that post-transcriptional regulation by two cross-talking noncoding RNAs, lnc-SCA7 and miR-124, mediates the tissue specificity of SCA7 pathology. Using two SCA7 mouse models, we showed that levels of miR-124 decrease, owing to reduced transcriptional activation activity of the STAGA complex as a result of ATXN7 mutation; thereafter, lower miR-124 levels contribute to the increased abundance of ATXN7 transcripts. These molecular interactions are expected to be more prevalent in the retina and cerebellum-the two tissues in which miR-124 is most highly expressed and exerts the strongest control on ATXN7 transcript abundance-mirroring the cell-specific pathology of SCA7. Post-transcriptional cross-talk between ATXN7 and lnc-SCA7 transcripts is likely to amplify the cellular impact of aberrant miR-124 levels. Nuclear aggregates of mutant ATXN7 protein are often found in the retina and cerebellum of SCA7-affected individuals 34 , and although it remains unclear whether these inclusions are the underlying cause or are a consequence of disease pathology, their presence and the mechanisms leading to their degradation are associated with increased cytotoxicity and disease severity 45 . We propose that, in patients with SCA7, increased levels of mutant ATXN7 protein result from its transcript's cell-specific post-transcriptional derepression due to decreased miR-124 abundance, and these high protein levels then lead to increased cytotoxic nuclear inclusions, primarily in the retina and the cerebellum (Fig. 4) .
DISCUSSION
miR-124 has been previously associated with neurodegeneration. Its levels are known to be dysregulated in the brains of patients with Huntington's disease 9 . Furthermore, some patients with Friedreich's ataxia (FRDA) carry mutations in miR-124-binding sites within the 3′ UTR of their FRDA-associated frataxin (FXN) gene, and these are associated with mRNA upregulation in vitro 46 . Here we have described how cerebellum-and retina-specific decreases in miR-124 levels in patients with SCA7 contribute to cell-specific degeneration. We show that changes in miR-124 levels also affect the abundance of other known miRNA targets including some that are involved in transcriptional regulation in the cerebellum 47 or in the control of retinal differentiation 48 . We predict that dysregulation of miR-124 targets contributes further to the neuronal specificity of the SCA7 phenotype.
Although the contributions of miRNAs to transcriptional regulation and disease are becoming more recognized, those of longer (>200 nt) counterparts remain poorly understood. We have shown that a conserved lncRNA, lnc-SCA7, post-transcriptionally regulates the expression of ATXN7 as well as many STAGA-encoding genes (Supplementary Note). Although the cross-talk between lnc-SCA7 and ATXN7 transcripts is likely to be ubiquitous, as highlighted by their correlated expression levels outside the CNS, it is greatly enhanced in the CNS, most prominently in the retina and the cerebellum, where miR-124 is most abundant. This tissue specificity of the cross-talk between coding and noncoding transcripts supports a functional role for lnc-SCA7 as a key modulator of ATXN7 expression in these tissues. Recently, deletion of the 12q21 chromosomal region containing the lnc-SCA7 and KCNC2 loci was shown to be associated with familial neurodevelopmental delay and cerebellar ataxia 49 . Both genes were proposed to account for the complex neurodevelopmental phenotype observed in this family 49 . Because the crosstalk between lnc-SCA7 and ATXN7 transcripts is most prominent in the cerebellum, we propose that loss-of-function mutations in the lnc-SCA7 locus may underlie the associated ataxia-like symptoms.
Our results provide much-needed insight into the contributions to human disease of noncoding RNAs, specifically those that confer the cell-specific disease pathology caused by mutations in ubiquitously expressed genes. Identifying additional noncoding RNAs that contribute to the tissue specificity in other diseases should further improve understanding of how RNA cross-talk modulates disease phenotypes.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Human and mouse gene expression profiling. Microarray gene expression data for ATXN7 and lnc-SCA7, also known as ATXN7L3B, were obtained from Gene Expression Atlas (GNF) through BioGPS (http://biogps.org/) for humans 50 , and their correlation coefficient (Pearson's correlation, R 2 ) was computed across all 59 available tissues or cells where both loci were expressed (AD >20, Pearson's R 2 = 0.24, P <0.05; data not shown).
Total RNA from 20 human normal adult tissues (adipose, bladder, brain, cervix, colon, esophagus, heart, kidney, liver, lung, ovary, placenta, prostate, skeletal muscle, small intestine, spleen, testes, thymus, thyroid and trachea) and 11 mouse normal adult tissues (bladder, brain, colon, heart, kidney, liver, lung, pancreas, skeletal muscle, small intestine and stomach) were acquired (FirstChoice Human Total RNA Survey Panel from Invitrogen, and mouse panel from Amsbio). Total RNA from mouse retina and eight brain tissues (cerebellum, cortex, entorhinal cortex, hippocampus, hypothalamus, medulla, olfactory bulb and striatum) was extracted with TRIzol (Invitrogen). Tissues were pooled from seven postnatal day 5 mice before extraction. RNA from mouse retina was extracted from wild-type (WT) C57BL/6 mice (pooled from two animals), and human retinal RNA was extracted from human WERI neuroblastoma cells with the RNeasy kit (Qiagen).
RNA was reverse transcribed into cDNA with a QuantiTect Reverse Transcription kit (Qiagen) according to the manufacturer's instructions. Expression levels were estimated by real-time quantitative PCR (qRT-PCR) on a StepOne Real-Time PCR thermocycler (ABI) with SYBR green PCR Master Mix (ABI) and loci-specific primers ( Supplementary Table 4 ) in triplicate. Non-reverse-transcribed RNA was used as a negative amplification control.
Western blotting. N2A whole cell extracts were lysed with RIPA buffer (Sigma), and the protein concentration was determined with the BCA assay kit (Pierce). 100 µg of protein was loaded onto a 4-20% Tris-glycine gel (Invitrogen) and separated by gel electrophoresis, and then transferred onto a PVDF membrane in 1× transfer buffer (48 mM Tris, 39 mM glycine, and 20% methanol) at 40 V for 2 h. The membrane was stained with Ponceau S (Sigma P7170-1L) according to the manufacturer's guidelines and destained with water.
The membrane was blocked (with 5% skimmed milk) for 1 h and incubated overnight in TBS-T buffer (0.9% NaCl, 100 nM Tris, and 1% Tween20) with the primary antibodies anti-Atxn7 (sc-21110, Santa Cruz Biotechnology, working dilution 1:200) and custom anti-lnc-SCA7/Atxn7l3 (Amsbio, working dilution 1:100) at 4 °C. The membrane was washed four times for 30 min in TBS-T and incubated with biotinylated secondary antibodies (ab6884 and ab7089, Abcam) for Atxn7 and putative lnc-SCA7/Atxn7l3, respectively, 1:5,000) for 1 h. This was followed by washes in TBS-T and incubation with horseradish peroxidase-conjugated streptavidin (ab7403, Abcam, 1:10,000) for an additional hour. Enhanced chemiluminesence detection was performed as recommended by the manufacturer (Amersham). The membrane was incubated twice for 10 min in stripping buffer, (25 mM glycine, 1% SDS, and 0.1% Tween 20); this was followed by two washes in PBS for 10 min and two washes in TBS-T for 5 min. The membrane was then blocked and reprobed with a positive-control antibody, anti-α-tubulin (ab7291, Abcam, working dilution 1:5,000); this was followed by the detection procedure described above (secondary antibody, ab64255). Commercial antibodies were validated by manufacturer as stated on their websites. Original images of blots used in this study can be found in Supplementary Data Set 1.
Knockdown and overexpression constructs. Three small interfering RNA (siRNA) constructs were designed with the siRNA-selection program from the Whitehead Institute 51 to specifically target lnc-SCA7 ( Supplementary Fig. 2a and Supplementary Table 4 ). For a control, we used an oligonucleotide with no significant sequence similarity to mRNAs in the mouse genome and with similar nucleotide composition (scrambled control; Supplementary Table 4 ). siRNAs and scrambled control were used to create short hairpin RNAs (shRNAs) by linking the two arms of the hairpin (loop sequence TTCAAGAGA). HPLCpurified custom-made oligonucleotides (10 mM, Sigma-Aldrich) were annealed in annealing buffer (10 mM Tris, pH 8, and 50 mM NaCl) at 95 °C for 5 min. After being cooled to room temperature, oligonucleotides were phosphorylated with T4 Polynucleotide Kinase (NEB) and cloned downstream of a U6 promoter from a modified pll3.7 vector (courtesy of E. Becker). The shRNA construct that had the greatest impact on lnc-SCA7 levels (Supplementary Fig. 2b ) was used in subsequent experiments. Three stable lnc-SCA7-knockdown and control N2A polyclonal cell lines were independently derived by cotransfection of the lnc-SCA7-knockdown and scrambled shRNA constructs with pTK-Hyg vector (courtesy of K. Vance). Cells were grown in hygromycin-containing medium (Invitrogen, 200 µg/mL) until high confluence was reached (after approximately 10 d). Medium was changed every 48 h.
Atxn7 3′ UTR (nucleotides 2,876-6,582, (ENSMUST00000022257), ENSEMBL Build 70, Atxn7-WT) and the putative 3′ noncoding untranslated sequences of mouse lnc-SCA7 (nucleotides 599-3,607, lnc-SCA7-WT), the full-length mouse lnc-SCA7 (lnc-SCA7-full) as well as lnc-SCA7-stop were cloned downstream of a CMV promoter on the pcDNA3.1(+) vector. lnc-SCA7-stop was generated by direct mutagenesis of position 14 of lnc-SCA7-full from C to A.
To disrupt miR-124-binding sites within lnc-SCA7-WT and Atxn7-WT, all miR-124 MRE regions complementary to the miRNA seed, 5′-TGCCTT-3′, within these constructs were mutated by reversing the sequence, with direct mutagenesis, to 5′-TTCCGT-3′. Empty pcDNA3.1(+) vector was used as transfection control in overexpression experiments.
Tissue culture. Mouse neuroblastoma (N2A) cells were grown at 37 °C in a humidified atmosphere supplemented with 5% CO 2 , in Dulbecco's Modified Eagle Medium (DMEM) containing antibiotic penicillin/streptomycin, supplemented with 10% fetal calf serum (FCS). Mouse DTCM23/49 XY embryonic stem (ES) cell lines were grown as described previously 52 . Deletion of Dcr's RNase III domain was induced by culturing the cells in the presence of 800 nM (Z)-4hydroxytamoxifen (4-OHT, Sigma); noninduced cells were treated with 0.1% ethanol and used as control. Both conditional and Dcr-deficient ES cells were routinely maintained on a feeder layer of mitomycin-inactivated mouse primary embryonic fibroblasts. Prior to the analyses, feeder cells were depleted from the cultures by preplating trypsinized cells for 25 min and transferring ES-enriched cell suspension to a new gelatin-coated plate in a culturing medium supplemented with leukemia inhibitory factor (Invitrogen) and 2i inhibitors (CHIR99021 at 3 nM and PD0325901 at 1 nM, Stemgent). After removal of the RNase III domain of Dcr, cells were kept for no longer than six passages.
Fibroblast cell lines derived from patients with SCA7 (SCA7 42Q/10Q , SCA7 49Q/10Q , and SCA7 55Q/10Q ) were incubated at 37 °C in 5% CO 2 in DMEM Glutamax (Gibco-BRL) supplemented with 10% FBS and antibiotics.
1 d before transfection, N2A or ES cells (1.0 × 10 5 cells/ml) were seeded in six-well dishes. Knockdown and overexpression constructs and their respective control constructs (1 µg) were transfected with FuGENE 6 Transfection Reagent (Roche) according to the manufacturer's guidelines. After transfection, cells were grown under standard conditions before harvesting. A miRNA's mimic (50 nM/well) (mirVana, ABI) and its negative control (cat. no. 4464058, ABI), or an siRNA (5 nM/well) (FlexiTube GS382423, Qiagen) and its negative control (cat. no. 1027280, Qiagen), were transfected with Lipofectamine RNAiMAX Reagent (Invitrogen). Cells were harvested 48 h after transfection.
RNA extraction and quantification. Total cellular RNA was extracted with the RNeasy kit (Qiagen) according to the manufacturer's instructions. To quantify levels of mature miRNAs, total RNA was extracted with the miRNeasy kit (Qiagen). Genomic DNA was removed with the DNA-free kit (Ambion). RNA was reverse transcribed, and cDNA was used to quantify gene expression changes, relative to Gapdh, with sequence-specific primers (Supplementary Table 4) , as described above.
For miRNA quantification, RNA was reverse transcribed with the TaqMan MicroRNA Reverse Transcription kit (Invitrogen). For comparison of miRNA expression between tissues, RNA was reverse transcribed with the NCode VILO miRNA cDNA Synthesis kit (Invitrogen). miRNA abundance was measured by qRT-PCR (SYBR green) with miRNA-specific TaqMan MicroRNA Assays (ABI) according to the manufacturer's instructions. The expression levels of miRNAs were normalized to that of 18S rRNA.
Mutagenesis. Directed mutagenesis of constructs was generated by PCR with 2 µl of reverse-transcribed cDNA with 300 mM of primers ( Supplementary  Table 4 ), 1 U Expand High Fidelity DNA polymerase (Roche), 1.5 mM MgCl 2 , 0.2 mM dNTPs, 5% DMSO and 10× buffer in 50 µl total volume. PCR reactions were carried out in a Veriti 96-well (Applied Biosystems) thermocycler as follows: 94 °C for 2 min; 5 cycles with 15 s at 94 °C, 15 s at a temperature gradient of 58-68 °C and 2 min at 94 °C; 15 cycles with 15 s at 94 °C, 30 s at a temperature analyses. In situ hybridization and qRT-PCR were also carried out from heterozygous SCA7 266Q/5Q mice (5 weeks of age, n = 3 for both experiments) and wild-type age-and sex-matched littermate controls (SCA7 5Q/5Q , n = 3 for each experiment). Biopsies from neuronal tissues (retina, cerebellum, cortex, striatum, olfactory bulb and spinal cord) were collected at 4 °C with an adult mouse brain matrix slicer. Non-neuronal tissues (liver, lung and muscle) were dissected at 4 °C. After dissection, biopsies were immediately frozen in liquid nitrogen and stored at −80 °C until RNA extraction. Tissues were homogenized in RLT buffer with 1% β-mercaptoethanol (RNeasy kit, Qiagen) and prepared for RNA extraction as described previously. Reverse transcription to cDNA was performed as described previously and was followed by gene expression detection by qRT-PCR.
In situ hybridization. Target sequences were generated by PCR or qRT-PCR and cloned into pCR4-TOPO (Invitrogen), and digoxigenin (DIG)-labeled riboprobes were synthesized from linearized plasmid DNA. Tissue samples were snap frozen in OCT (VWR), and 14-µm sections were cut with a cryostat (Leica) and mounted onto Superfrost Plus slides (VWR). For ATXN7, probe hybridization, washing and signal detection with an alkaline phosphatase-conjugated anti-DIG antibody was carried out as previously described 62 . Sense-strand probes were also tested to obtain a negative-control signal (data not shown). Primer sequences for riboprobe cloning of lnc-SCA7 and ATXN7 can be found in Supplementary Table 4 . For miR-124, a DIG-labeled LNA probe (Exiqon) was hybridized as above with some slight modifications 63 . To ensure that signals obtained before analysis were at subsaturation levels, the ATXN7 probe was hybridized for 16 h, whereas the miR-124 probe was hybridized for 4 h. SCA7 human fibroblasts. Transcript abundance of SCA7 fibroblast cell lines against that of a control fibroblast cell line (10Q/10Q) was quantified by qRT-PCR with SYBR green PCR Master Mix (Invitrogen) and target-specific primers in combination with a TaqMan (Invitrogen) probe (ATXN7, cat. no. 4331182, Invitrogen; GAPDH, cat. no. 4331182, Invitrogen; custom-made lnc-SCA7 probe (Supplementary Table 4) ). Results illustrated in Figure 5a Statistics. All expression correlation comparisons were determined with the Pearson's correlation test, and all differential expression comparisons were determined with Student's t test. Asterisks indicate significance in the level of the comparison between the expression of target transcripts (*P < 0.05; **P < 0.01; ***P < 0.001; not significant (NS), P > 0.05). For each experimental analysis, statistical values were calculated with data collected from three independent experiments.
